NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation No … ← NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation NEJM at ESC - Continuation versus Interruption of Oral Anticoagulation during TAVI →